DL-Arginine

DL-Arginine is a proteinogenic amino acid featuring a stereogenic center at the alpha carbon and a guanidinium side chain that is strongly basic under typical aqueous conditions. The molecule bears a primary amino group and a carboxylic acid, enabling salt formation, acid-base tuning, and straightforward participation in peptide coupling chemistry after appropriate protection strategies. The DL designation indicates a racemic mixture of L- and D-arginine enantiomers, which is relevant for experiments requiring defined stereochemical outcomes or for generating racemic building blocks for subsequent chiral resolution. The guanidinium functionality can engage in salt-bridge and hydrogen-bonding interactions, while the amino acid backbone supports conversion into protected amino acid derivatives, activated esters, or peptide-grade intermediates used across synthetic and biochemical workflows.

1. Peptide Synthesis

DL-Arginine is applied in peptide building block preparation and peptide coupling development where an arginine residue is required at defined positions. The guanidinium side chain and the alpha-amino/alpha-carboxyl groups necessitate protection-group planning, commonly using N-protecting strategies for the backbone and guanidinium-protecting approaches to control chemoselectivity during amide bond formation. Racemic composition can be used for generating mixed stereochemical peptide libraries, for method development in which stereochemistry is resolved downstream, or for producing reference materials for coupling studies. Downstream, protected DL-arginine derivatives can be incorporated into linear peptides and used to access arginine-containing analogs for structure-focused synthetic chemistry.

2. Chemical Biology Probes

DL-Arginine is used as a chemical biology intermediate for preparing guanidinium-rich probes and labeling reagents that exploit strong ionic and hydrogen-bonding interactions. The side-chain guanidinium group supports conjugation strategies such as salt formation with anionic partners, attachment to linkers via protected functional groups, and incorporation into peptide-like constructs for cell-surface or biomolecular binding assays. The presence of both amino and carboxy functionalities enables straightforward derivatization into esters, amides, or activated intermediates for bioconjugation workflows. Racemic material can be particularly relevant for generating stereochemically mixed probe sets used to map binding determinants and to support comparative studies of stereochemical effects.

3. Protein Engineering Studies

DL-Arginine serves as a reagent for protein engineering and in vitro protein chemistry where arginine-containing segments are synthesized or modified outside living systems. The amino acid's backbone functionality supports conversion into protected amino acid derivatives compatible with solid-phase or solution-phase peptide assembly, while the guanidinium side chain can be retained for charge-driven recognition features in designed sequences. Racemic starting material may be used to generate stereochemically heterogeneous peptide fragments for screening, for producing standards that test analytical methods, or for constructing peptide substrates used in enzyme mechanistic studies. The resulting arginine-bearing constructs can then be used to interrogate sequence-dependent interactions, post-synthetic modification routes, and molecular recognition behavior.

4. Amino Acid Derivatization

DL-Arginine is utilized in amino acid derivatization and protected amino acid synthesis to access activated intermediates for downstream functional group transformations. The carboxylic acid and primary amine enable conversion into amino acid esters, amide derivatives, or protected forms that support controlled reactivity during multi-step syntheses. Guanidinium chemistry can be harnessed to form salts, to install linkers through protected guanidinium strategies, and to generate derivatives suited for chromatographic standards or reagent-grade building blocks. Racemic composition can also be leveraged when the target derivative is intended for subsequent enantioselective resolution or when stereochemical purity is not the primary determinant of the intermediate's role.

5. Pharmaceutical Intermediate Preparation

DL-Arginine is applied as a process-relevant amino acid feedstock for manufacturing intermediate preparation in fine chemical and pharmaceutical supply chains. The molecule's functional group set supports conversion into protected amino acid derivatives and activated species that can be carried into peptide-like intermediates, salt forms, or guanidinium-containing fragments used in medicinal chemistry. The stereochemical mixture can be acceptable for certain intermediate stages where stereochemistry is controlled later by chiral resolution or by stereoselective steps in downstream synthesis. The resulting derivatives align with industrial amino acid chemistry practices that emphasize robust protection/deprotection compatibility, predictable acid-base behavior, and scalable transformation of amino acid building blocks into complex nitrogen-rich scaffolds.

6. Analytical Research Standards

DL-Arginine is used in analytical research for preparing reference materials and calibration components related to amino acid quantification, derivatization method development, and stereochemical evaluation workflows. The guanidinium side chain and the alpha-amino/alpha-carboxyl groups enable derivatization into detectable derivatives for chromatographic or spectrometric assays, and the racemic nature can support method validation where both enantiomers are monitored. Salt formation and controlled protection strategies can be employed to generate stable analytical forms that reflect the chemical behavior of arginine in complex matrices. The compound's defined structure makes it suitable for supporting amino acid profiling, monitoring of derivatization efficiency, and verification of peptide hydrolysis or amino acid release processes in applied analytical chemistry.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Implications of ligand-receptor binding kinetics on GLP-1R signalling

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)